Coloplast A/S (CPH: COLO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
797.20
+6.80 (0.86%)
Dec 20, 2024, 4:59 PM CET

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of DKK 179.48 billion. The enterprise value is 201.32 billion.

Market Cap 179.48B
Enterprise Value 201.32B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date Feb 4, 2025
Ex-Dividend Date Dec 6, 2024

Share Statistics

Coloplast has 225.14 million shares outstanding. The number of shares has increased by 4.36% in one year.

Current Share Class n/a
Shares Outstanding 225.14M
Shares Change (YoY) +4.36%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) 5.66%
Owned by Institutions (%) 24.36%
Float 141.36M

Valuation Ratios

The trailing PE ratio is 35.49 and the forward PE ratio is 30.95. Coloplast's PEG ratio is 2.74.

PE Ratio 35.49
Forward PE 30.95
PS Ratio 6.63
PB Ratio 10.00
P/TBV Ratio n/a
P/FCF Ratio 112.17
P/OCF Ratio n/a
PEG Ratio 2.74
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.75, with an EV/FCF ratio of 125.82.

EV / Earnings 39.85
EV / Sales 7.45
EV / EBITDA 23.75
EV / EBIT 27.54
EV / FCF 125.82

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.

Current Ratio 1.02
Quick Ratio 0.62
Debt / Equity 1.26
Debt / EBITDA 2.67
Debt / FCF 14.14
Interest Coverage 9.19

Financial Efficiency

Return on equity (ROE) is 28.67% and return on invested capital (ROIC) is 11.80%.

Return on Equity (ROE) 28.67%
Return on Assets (ROA) 9.49%
Return on Capital (ROIC) 11.80%
Revenue Per Employee 1.62M
Profits Per Employee 303,624
Employee Count 16,639
Asset Turnover 0.56
Inventory Turnover 2.44

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +4.78% in the last 52 weeks. The beta is 0.33, so Coloplast's price volatility has been lower than the market average.

Beta (5Y) 0.33
52-Week Price Change +4.78%
50-Day Moving Average 878.00
200-Day Moving Average 883.55
Relative Strength Index (RSI) 29.50
Average Volume (20 Days) 226,564

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Coloplast had revenue of DKK 27.03 billion and earned 5.05 billion in profits. Earnings per share was 22.46.

Revenue 27.03B
Gross Profit 18.27B
Operating Income 7.31B
Pretax Income 6.40B
Net Income 5.05B
EBITDA 8.19B
EBIT 7.31B
Earnings Per Share (EPS) 22.46
Full Income Statement

Balance Sheet

The company has 788.00 million in cash and 22.63 billion in debt, giving a net cash position of -21.84 billion or -97.01 per share.

Cash & Cash Equivalents 788.00M
Total Debt 22.63B
Net Cash -21.84B
Net Cash Per Share -97.01
Equity (Book Value) 17.94B
Book Value Per Share 79.69
Working Capital 240.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.77 billion and capital expenditures -1.17 billion, giving a free cash flow of 1.60 billion.

Operating Cash Flow 2.77B
Capital Expenditures -1.17B
Free Cash Flow 1.60B
FCF Per Share 7.11
Full Cash Flow Statement

Margins

Gross margin is 67.59%, with operating and profit margins of 27.04% and 18.69%.

Gross Margin 67.59%
Operating Margin 27.04%
Pretax Margin 23.66%
Profit Margin 18.69%
EBITDA Margin 30.30%
EBIT Margin 27.04%
FCF Margin 5.92%

Dividends & Yields

This stock pays an annual dividend of 22.00, which amounts to a dividend yield of 2.76%.

Dividend Per Share 22.00
Dividend Yield 2.76%
Dividend Growth (YoY) 4.76%
Years of Dividend Growth 11
Payout Ratio 93.43%
Buyback Yield -4.36%
Shareholder Yield -1.60%
Earnings Yield 2.82%
FCF Yield 0.89%
Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date Dec 19, 2012
Split Type Forward
Split Ratio 5

Scores

Coloplast has an Altman Z-Score of 5.4.

Altman Z-Score 5.4
Piotroski F-Score n/a